Skip to main content
Erschienen in: BMC Pulmonary Medicine 1/2013

Open Access 01.12.2013 | Case report

Pulmonary focal fibrosis associated with microscopic arterio-venous fistula manifesting as focal ground-glass opacity on thin-section CT

verfasst von: Noriko Sudo, Atsushi Nambu, Takana Yamakawa, Masashi Kawamoto, Shozo Fujino, Masato Watanabe, Kunio Mizuguchi, Masao Tago

Erschienen in: BMC Pulmonary Medicine | Ausgabe 1/2013

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Focal ground-glass opacity (GGO) on thin-section computed tomography (CT) may be seen in atypical adenomatous hyperplasia (AAH), adenocarcinoma in situ that has recently been renamed from bronchioloalveolar carcinoma (BAC) and various benign conditions.

Case presentation

We report a case of pulmonary focal fibrosis associated with microscopic arterio-venous fistula (AVF), which showed a focal area of GGO on thin-section CT. The patient was a 58-year-old woman with a GGO on thin-section CT which had increased in size over the period of 2 years. Slightly dilated vessels and thickened interlobular septa were also noted around the GGO. It was diagnosed preoperatively as adenocarcinoma in situ and a partial lung resection by video-assisted thoracic surgery (VATS) was performed. Pathological examination yielded a diagnosis of focal fibrosis associated with microscopic AVF.

Conclusion

We speculate that the focal fibrosis was produced by a prolonged congestion due to the AVF and that the dilated vessels and thickening of interlobular septa on thin-section CT related to the AVF. Microscopic AVF may be one of the etiologies of focal fibrosis showing focal GGO on thins-section CT. Dilated vessels and thickened interlobular septa around the GGO might offer a clue to the diagnosis of this disease entity. In addition, it should be noted that focal fibrosis may increase in size.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1471-2466-13-3) contains supplementary material, which is available to authorized users.

Competing interests

We have no competing interests.

Authors’ contributions

NS drafted the initial manuscript and modified it in reference to the other authors’ opinion. AN, TY and MT edited the manuscript. MK, SF, MW and KM were involved in diagnostics and treatment of the patient and provided advice to me in each of their expertise areas. All authors read and approved the final manuscript.
Abkürzungen
AVF
Arterio-venous fistula
GGO
Ground-glass opacity
CT
Computed tomography
BAC
Bronchioalveolar carcinoma
VATS
Video-assisted thoracic surgery
AAH
Adenomatous hyperplasia
AVM
Arteriovenous malformation
18F-FDG PET
F-18 fluorodeoxyglucose positron emission tomography.

Background

Recently, widespread use of computed tomography (CT) for lung cancer screening allows us to detect many faint peripheral pulmonary lesions. Radiologists have come to encounter focal ground-glass opacity (GGO) more frequently than before. Persistent focal GGO is most commonly seen in atypical adenomatous hyperplasia (AAH) and adenocarcinoma in situ that has recently been renamed from bronchioloalveolar carcinoma (BAC) in the revised classification [1]. Focal GGO may also be seen in various benign conditions, including focal fibrosis, focal inflammation, or hemorrhage [2, 3]. Focal fibrosis accounts for approximately 15% of focal pure GGO [4]. However its etiology is still unknown.
Herein, we present a case of focal fibrosis associated with microscopic arterio-venous fistula (AVF) manifesting as focal GGO mimicking adenocarcinoma in situ on chest CT, which suggested a pathogenesis of focal fibrosis.

Case presentation

A 58-year-old woman was referred to our hospital for detailed evaluation of focal GGO that had been discovered by a screening CT two years before. Thirteen years earlier, the patient had undergone a partial left lung resection for pulmonary hamartoma. Biochemical tests and tumor markers for lung cancer on admission were within the normal ranges. Her physical condition was good with no clinical symptoms. She had never smoked. Chest thin-section CT scan showed a 10-mm pure GGO with a well-defined and smooth margin in the right upper lobe (Figure 1a). In addition, slightly dilated veins and thickening of interlobular septa were seen around the focal GGO (Figure 1a, b).
The focal GGO was identifiable also on the previous CT for lung cancer screening when viewed retrospectively (Figure 2). It had increased in size for 2 years. The lesion was not identified on chest radiograph. Adenocarcinoma in situ was considered likely due to the presence of an interval increase of the GGO. The lesion was resected by video-assisted thoracic surgery (VATS). It was unidentifiable during the surgery. Histopathological examination of the resected lung tissue revealed no evidence of malignancy but abnormally dilated arterioles, venules and lymph ducts with an area of peripheral focal fibrosis consisting of congestion, fibrotic septal thickening with preservation of the intraalveolar airspaces (Figure 3a–c). This focal fibrosis was considered to correspond to the focal GGO on thin-section CT. The dilated arterioles had thickened walls and were directly communicating with the venules (Figure 3c). These histopathological findings were similar to those of arteriovenous malformation (AVM). However, the present case showed no significant evidence of nidus and it was unknown whether these vascular abnormalities were congenital or not. Therefore, we regarded it as microscopic AVF.

Discussion

Pure GGO that is persistently (either no change or an increase in diameter for ≧1 month) present on serial thin-section CT scans suggests the possibility of AAH, adenocarcinoma in situ, pulmonary lymphoproliferative disorder, or organizing pneumonia/focal fibrosis [5]. The most common diseases showing persistent focal GGO are AAH and adenocarcinoma in situ. Focal fibrosis is a relatively rare disease entity constituting 15–21% of persistent focal GGO [3, 4].
The pathogenesis of focal fibrosis is still not well understood. It may represent a focal tissue response to local lung injury due to infection or radiation, drug, or physical pressure [6]. In our case, microscopic AVF coexisted with the focal fibrosis. We speculate that prolonged localized congestion caused by AVF lead to focal tissue fibrosis. Of note in our case is that the focal fibrosis had increased in size during the time interval between the two CT examinations. As congestion associated with AVF is considered a chronic pathophysiological process, the fibrosis may have gradually extended.
Focal fibrosis has been described as sharply demarcated nodular GGO with a maximal diameter of less than 2 cm on thin-section CT [4]. Solid components which pathologically correspond to compact fibrotic foci or alveolar collapse may be present. These imaging features are shared by both focal fibrosis and AAH/ adenocarcinoma in situ. Therefore, the differentiation between these lesions by CT images is difficult. One possible discriminating feature may be that focal fibrosis does not increase in size over a considerable period of time [6]. However, our case showed an interval growth over a few years.
F-18 fluorodeoxyglucose positron emission tomography (18F-FDG PET) has increasingly been used in the evaluation of lung cancer. It is also useful for differentiating between malignant and benign nodules. However, as for focal GGO, it has been shown that 18F-FDG PET has limited value in the evaluation of focal GGOs for determining nodule malignancy and staging in comparison with solid nodules. Chun et al. [7] reported that in pure GGOs, both inflammation and malignancy showed an SUV less than 1.0 and did not show a statistically significant difference. Therefore, 18F-FDG PET is considered to contribute little to the differentiation between adenocarcinoma in situ and focal fibrosis.
A well-known imaging feature of pulmonary AVF is dilatation of the feeding artery and draining vein with a nodular area where these vessels join. We couldn’t see such a nodular area in our case probably because the AVF was microscopic and thus was too small to see on CT. However, slightly dilated veins and thickened interlobular septa were demonstrated around the focal GGO on thin-section CT. We think that these findings related to the AVF and may be a clue to the differentiation between this disease entity and AAH/adenocarcinoma in situ.

Conclusions

In summary, we presented a rare case of focal fibrosis associated with microscopic AVF that showed focal GGO on thin-section CT. To our knowledge, this is the first report of this disease entity. Although the CT findings are similar to those of AAH/adenocarcinoma in situ, dilated vessels and thickened interlobular septa around the GGO might offer a clue to the differential diagnosis. Additionally, it should be noted that focal fibrosis may increase in size.
Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

We have no competing interests.

Authors’ contributions

NS drafted the initial manuscript and modified it in reference to the other authors’ opinion. AN, TY and MT edited the manuscript. MK, SF, MW and KM were involved in diagnostics and treatment of the patient and provided advice to me in each of their expertise areas. All authors read and approved the final manuscript.
Anhänge

Authors’ original submitted files for images

Literatur
1.
Zurück zum Zitat Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, Garg K, Austin JH, Asamura H, Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, Ishikawa Y, Jett J, Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J, Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D, et al: International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011, 6: 244-285. 10.1097/JTO.0b013e318206a221.CrossRefPubMedPubMedCentral Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, Garg K, Austin JH, Asamura H, Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, Ishikawa Y, Jett J, Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J, Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D, et al: International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011, 6: 244-285. 10.1097/JTO.0b013e318206a221.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Chang MP, Jin MG, Hyun JL, Chang HL, Eun JC, Jung-Gi I: Nodular ground-glass opacity at thin-section CT: histopathologic correlation and evaluation of change at follow-up. RadioGraphics. 2007, 27: 391-408. 10.1148/rg.272065061.CrossRef Chang MP, Jin MG, Hyun JL, Chang HL, Eun JC, Jung-Gi I: Nodular ground-glass opacity at thin-section CT: histopathologic correlation and evaluation of change at follow-up. RadioGraphics. 2007, 27: 391-408. 10.1148/rg.272065061.CrossRef
3.
Zurück zum Zitat Collins J, Stern EJ: Ground-glass opacity at CT: The ABCs. AJR Am J Roentgenol. 1997, 169: 355-367.CrossRefPubMed Collins J, Stern EJ: Ground-glass opacity at CT: The ABCs. AJR Am J Roentgenol. 1997, 169: 355-367.CrossRefPubMed
4.
Zurück zum Zitat Nakajima R, Yokose T, Kakinuma R, Nagai K, Nishiwaki Y, Ochiai A: Localized pure ground-glass opacity on high-resolution CT: histologic characteristics. J Comput Assist Tomogr. 2002, 26: 323-329. 10.1097/00004728-200205000-00001.CrossRefPubMed Nakajima R, Yokose T, Kakinuma R, Nagai K, Nishiwaki Y, Ochiai A: Localized pure ground-glass opacity on high-resolution CT: histologic characteristics. J Comput Assist Tomogr. 2002, 26: 323-329. 10.1097/00004728-200205000-00001.CrossRefPubMed
5.
Zurück zum Zitat Kim HY, Shim YM, Lee KS, Han J, Yi CA, Kim YK: Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic histopathologic comparisons. Radiology. 2007, 245: 267-275. 10.1148/radiol.2451061682.CrossRefPubMed Kim HY, Shim YM, Lee KS, Han J, Yi CA, Kim YK: Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic histopathologic comparisons. Radiology. 2007, 245: 267-275. 10.1148/radiol.2451061682.CrossRefPubMed
6.
Zurück zum Zitat Chang MP, Jin MG, Hyun JL, Doo HC, Eun JC, Jung-Gi I: Focal interstitial fibrosis manifesting as nodular ground-glass opacity: thin-section CT findings. Eur Radiol. 2007, 17: 2325-2331. 10.1007/s00330-007-0596-z.CrossRef Chang MP, Jin MG, Hyun JL, Doo HC, Eun JC, Jung-Gi I: Focal interstitial fibrosis manifesting as nodular ground-glass opacity: thin-section CT findings. Eur Radiol. 2007, 17: 2325-2331. 10.1007/s00330-007-0596-z.CrossRef
7.
Zurück zum Zitat Chun EJ, Lee HJ, Kang WJ, Kim KG, Goo JM, Park CM, Lee CH: Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: the feasibility of integrated 18F-FDG PET/CT. Lung Cancer. 2009, 65: 180-186. 10.1016/j.lungcan.2008.11.015.CrossRefPubMed Chun EJ, Lee HJ, Kang WJ, Kim KG, Goo JM, Park CM, Lee CH: Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: the feasibility of integrated 18F-FDG PET/CT. Lung Cancer. 2009, 65: 180-186. 10.1016/j.lungcan.2008.11.015.CrossRefPubMed
Metadaten
Titel
Pulmonary focal fibrosis associated with microscopic arterio-venous fistula manifesting as focal ground-glass opacity on thin-section CT
verfasst von
Noriko Sudo
Atsushi Nambu
Takana Yamakawa
Masashi Kawamoto
Shozo Fujino
Masato Watanabe
Kunio Mizuguchi
Masao Tago
Publikationsdatum
01.12.2013
Verlag
BioMed Central
Erschienen in
BMC Pulmonary Medicine / Ausgabe 1/2013
Elektronische ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-13-3

Weitere Artikel der Ausgabe 1/2013

BMC Pulmonary Medicine 1/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.